Skip to Content

Lannett 1782 250 mg (Temozolomide 250 mg)

Pill with imprint Lannett 1782 250 mg is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Lannett Company, Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lannett 1782 250 mg

Temozolomide

Imprint
Lannett 1782 250 mg
Strength
250 mg
Color
White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lannett Company, Inc.
National Drug Code (NDC)
00527-1782
Inactive Ingredients
mannitol, croscarmellose sodium, stearic acid, citric acid anhydrous, silicon dioxide, sodium lauryl sulfate, gelatin, titanium dioxide, shellac, alcohol, ferrosoferric oxide, butyl alcohol, propylene glycol, methyl alcohol, FD&C Blue No. 2, FD&C Red No. 40, FD&C Blue No. 1, D&C Yellow No. 10, aluminum oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.